Clinical Trial

Composite Dietary Antioxidant Index and Metabolic Health in Overweight/Obesity in U.S. Adults

Withdrawn
View on ClinicalTrials.gov →
Why the trial stopped
This study is a retrospective analysis of de-identified public database data. As no participants were ever enrolled, the status is updated to Withdrawn to accurately reflect that no enrollment occurred.
Summary
This cross-sectional study draws on data from the National Health and Nutrition Examination Survey (NHANES) database. The primary objective is to investigate the associations between the Composite Dietary Antioxidant Index (CDAI) and overweight/obesity, as well as the related metabolic abnormalities, among the U.S. general population. By analyzing this large-scale, nationally representative dataset, the investigators seek to generate evidence that can inform public health policies and clinical practice-ultimately contributing to a deeper understanding of population-level health challenges and the development of targeted strategies to address them.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-04.
Status change: Completed → Withdrawn 2026-02-12
Trial Details
NCT Number NCT07291726
Lead Sponsor University-Town Hospital of Chongqing Medical University
Conditions Overweight/Obesity, Metabolic Health
Start Date 2024-04-01
Primary Completion 2024-07-04 (estimated)
Study Completion 2024-08-06 (estimated)
Updated on ClinicalTrials.gov 2026-02-17